Journal of opioid management · 2023
Analgesic methadone prescribing in community health centers among patients with chronic pain.
Наблюдательное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bailey Steffani R, O'Malley Jean P, Hartung Daniel M, Huguet Nathalie, Marino Miguel, Muench John
Аннотация
OBJECTIVE: To examine analgesic methadone prescriptions among community health center (CHC) patients with chronic pain.
DESIGN: Observational; two cross-sectional periods.
SETTING: Oregon and California CHCs.
PATIENTS: Chronic pain patients with ≥1 visit in 2012-2013 or 2017-2018 (N = 158,239).
OUTCOMES: Changes in adjusted relative rates (aRRs) of receiving no opioids, short-acting only, long-acting only other than methadone, and methadone; characteristics associated with ≥1 methadone prescription.
RESULTS: Opioid prescribing declined over time, with the largest decrease in methadone (aRR = 0.19, 95 percent confidence interval: 0.14-0.27). Among patients receiving ≥1 long-acting opioid, variables associated with methadone prescribing included being aged <65 years, having nonprivate insurance, and an opioid use disorder (OUD) diagnosis. From 2012-2013 to 2017-2018, aRR increased among patients with OUD and decreased for those aged 18-30 (vs ≥65), uninsured and Medicaid-insured (vs private), and race/ethnicity other than non-Hispanic Black (vs non-Hispanic White).
CONCLUSIONS: Methadone prescribing decreased in CHCs but remained elevated for several high-risk demographic groups.
DESIGN: Observational; two cross-sectional periods.
SETTING: Oregon and California CHCs.
PATIENTS: Chronic pain patients with ≥1 visit in 2012-2013 or 2017-2018 (N = 158,239).
OUTCOMES: Changes in adjusted relative rates (aRRs) of receiving no opioids, short-acting only, long-acting only other than methadone, and methadone; characteristics associated with ≥1 methadone prescription.
RESULTS: Opioid prescribing declined over time, with the largest decrease in methadone (aRR = 0.19, 95 percent confidence interval: 0.14-0.27). Among patients receiving ≥1 long-acting opioid, variables associated with methadone prescribing included being aged <65 years, having nonprivate insurance, and an opioid use disorder (OUD) diagnosis. From 2012-2013 to 2017-2018, aRR increased among patients with OUD and decreased for those aged 18-30 (vs ≥65), uninsured and Medicaid-insured (vs private), and race/ethnicity other than non-Hispanic Black (vs non-Hispanic White).
CONCLUSIONS: Methadone prescribing decreased in CHCs but remained elevated for several high-risk demographic groups.